Our results suggest that 4 weeks of EA treatment can improve both CUMS-induced depression-like behaviour and hippocampal synaptic plasticity in rats, and the mechanism may be related to the inhibition of the GluN2B/CaMKII/CREB pathway. Here, GRIN2B is linked to depressive symptom measurement.